Scleroderma renal crisis: pathogenesis issues, disease pattern and modern approaches to the treatment
Journal Title: Нирки - Year 2018, Vol 7, Issue 4
Abstract
Scleroderma renal crisis (SRC) is a major complication in patients with systemic sclerosis. SRC occurs in about 5–25 % of all patients with scleroderma. It is characterized by malignant hypertension and olig-/anuric acute renal failure. Around 10 % of SRC cases may present with normal blood pressure, termed normotensive renal crisis. The etiopathogenesis is presumed to be a series of insults to the kidneys resulting in endothelial injury, intimal proliferation, and narrowing of renal arterioles leading to decreased blood flow, hyperplasia of the juxtaglomerular apparatus, hyperreninemia, and accelerated hypertension. SRC is often triggered by nephrotoxic drugs and/or intravascular volume depletion. SRC occurs particularly in the first years of disease and in its diffuse form. The occurrence of SRC is more common in patients treated with glucocorticoids, the risk increases with increasing dose. Left ventricular insufficiency and hypertensive encephalopathy are typical clinical features. Thrombotic microangiopathy is detected in 43 % of the cases. Anti-RNA-polymerase III antibodies are present in one third of patients who develop SRC. Renal biopsy is not necessary if SRC presents with classical features. However, it can help to establish prognosis and approaches to the treatment in atypical forms. The prognosis of SRC has dramatically improved with the introduction of angiotensin-converting enzyme inhibitors. However, 5-year survival in patients with systemic sclerosis who develop the full picture of SRC remains low (65 %). The treatment of SRC is based on aggressive control of blood pressure with angiotensin-converting enzyme inhibitors, if needed, in combination with other types of antihypertensive drugs. Dialysis is frequently indicated, but can be stopped in approximately half of patients, mainly in those with good control of blood pressure. Patients who need dialysis for more than 2 years qualify for renal transplantation. SRC still remains an important cause of morbidity and mortality in scleroderma. Prompt diagnosis and treatment may help prevent adverse outcomes and improve survival.
Authors and Affiliations
I. Yu. Golovach, Ye. D. Yehudina
Keywords
Related Articles
- EP ID EP421443
- DOI 10.22141/2307-1257.7.4.2018.148521
- Views 82
- Downloads 0
Kidney damage associated with anti-phospholipid syndrome
Antiphospholipid syndrome (APS) is a common autoimmune disease caused by pathogenic antiphospholipid antibodies, leading to recurrent thrombosis and/or obstetric complications. It is important for nephrologists to know t...
CAKUT-Syndrome and Chronic Kidney Disease: the Concept of Nephrology Approach
This article presents the results of the analysis of the etiological structure of chronic kidney disease (CKD) in Kyiv children from 2006 to 2015. In the structure of CKD, CAKUT-syndrome dominates — from 62.3 % (2013) to...
Pathophysiological and Methodological Aspects of Determining Renal Functional Reserve in Clinical Nephrology
The article pathogenetically substantiates the feasibility of using methods for determining functional renal reserve through salt and water loading of 0.5% sodium chloride in an amount of 0.5 % of the body weight in pati...
Percutaneous Puncture Nephrostomy — Method of Choice in the Treatment of Patients with Full Obstruction in Upper Urinary Tracts and Renal Failure
There has been defined the role of percutaneous puncture nephrostomy in treatment of patients with full obstruction in the upper urinary tracts and renal failure. There has been detected the highest positive dynamics of...
The current strategy was the use of neuroprotective protein diet purposes.
This article provides an overview of the scientific evidences on the use of low-protein diet by patients with chronic kidney disease. Their analysis show that low-protein diet refers to the recommendations of a high lave...